Home › Idiopathic Pulmonary Fibrosis › Kentucky › Lexington
Idiopathic Pulmonary Fibrosis clinical trials in Lexington, KY
3 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in and around Lexington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
RecruitingPhase 3
- University of Kentucky - Div. of Pulmonary, Critical Care, and Sleep Medicine, Lexington
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- University of Kentucky, Lexington
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
RecruitingPhase 2
- Research Site, Lexington
Idiopathic Pulmonary Fibrosis trials in other cities
- Philadelphia, PA9 studies
- Birmingham, AL8 studies
- New York City, NY7 studies
- Los Angeles, CA6 studies
- Chicago, IL6 studies
- Kansas City, KS6 studies
- Durham, NC6 studies
- Aurora, CO6 studies
- Winston-Salem, NC5 studies
- Nashville, TN5 studies
- Houston, TX5 studies
- El Paso, TX5 studies
Other studies in Lexington
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Ovarian Cancer15 studies
- Cancer (all types)14 studies
- Breast Cancer13 studies
- Prostate Cancer12 studies
- Obesity12 studies
- Acute Myeloid Leukemia11 studies
- Colorectal Cancer11 studies
- Metastatic Cancer10 studies
- Head and Neck Squamous Cell Carcinoma9 studies
- Heart Failure9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.